Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study

por Sato, Kosuke, Inoue, Jun, Akahane, Takehiro, Kobayashi, Tomoo, Sato, Shuichi, Kisara, Norihiro, Ninomiya, Masashi, Iwata, Tomoaki, Sano, Akitoshi, Tsuruoka, Mio, Onuki, Masazumi, Masamune, Atsushi
Publicado 2022

Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma

por Tsuruoka, Mio, Inoue, Jun, Ouchi, Keishi, Uno, Kaname, Itami, Hideaki, Ninomiya, Masashi, Iwata, Tomoaki, Sano, Akitoshi, Sato, Kosuke, Onuki, Masazumi, Sawahashi, Satoko, Koike, Tomoyuki, Masamune, Atsushi
Publicado 2022

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective...

por Inoue, Jun, Kobayashi, Tomoo, Akahane, Takehiro, Kimura, Osamu, Sato, Kosuke, Ninomiya, Masashi, Iwata, Tomoaki, Takai, Satoshi, Kisara, Norihiro, Sato, Toshihiro, Nagasaki, Futoshi, Miura, Masahito, Nakamura, Takuya, Umetsu, Teruyuki, Sano, Akitoshi, Tsuruoka, Mio, Onuki, Masazumi, Niitsuma, Hirofumi, Masamune, Atsushi
Publicado 2022

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage

por Ninomiya, Masashi, Tsuruoka, Mio, Inoue, Jun, Hiraoka, Atsushi, Iwata, Tomoaki, Sano, Akitoshi, Sato, Kosuke, Onuki, Masazumi, Sawahashi, Satoko, Kuroda, Hidekatsu, Oikawa, Takayoshi, Fujita, Masashi, Abe, Kazumichi, Katsumi, Tomohiro, Sato, Wataru, Igarashi, Go, Iino, Chikara, Endo, Tetsu, Tanabe, Nobukazu, Numao, Hiroshi, Iijima, Katsunori, Matsumoto, Takayuki, Ohira, Hiromasa, Ueno, Yoshiyuki, Masamune, Atsushi
Publicado 2023